Anti-KAIN/ SERPINA4/ KAL functional antibody

Anti-KAIN/ SERPINA4/ KAL functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SERPINA4/SERPINA4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1278-Ab-1/ GM-Tg-hg-SE1278-Ab-2Anti-Human SERPINA4 monoclonal antibodyHuman
GM-Tg-rg-SE1278-Ab-1/ GM-Tg-rg-SE1278-Ab-2Anti-Rat SERPINA4 monoclonal antibodyRat
GM-Tg-mg-SE1278-Ab-1/ GM-Tg-mg-SE1278-Ab-2Anti-Mouse SERPINA4 monoclonal antibodyMouse
GM-Tg-cynog-SE1278-Ab-1/ GM-Tg-cynog-SE1278-Ab-2Anti-Cynomolgus/ Rhesus macaque SERPINA4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1278-Ab-1/ GM-Tg-felg-SE1278-Ab-2Anti-Feline SERPINA4 monoclonal antibodyFeline
GM-Tg-cang-SE1278-Ab-1/ GM-Tg-cang-SE1278-Ab-2Anti-Canine SERPINA4 monoclonal antibodyCanine
GM-Tg-bovg-SE1278-Ab-1/ GM-Tg-bovg-SE1278-Ab-2Anti-Bovine SERPINA4 monoclonal antibodyBovine
GM-Tg-equg-SE1278-Ab-1/ GM-Tg-equg-SE1278-Ab-2Anti-Equine SERPINA4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1278-Ab-1/ GM-Tg-hg-SE1278-Ab-2; GM-Tg-rg-SE1278-Ab-1/ GM-Tg-rg-SE1278-Ab-2;
GM-Tg-mg-SE1278-Ab-1/ GM-Tg-mg-SE1278-Ab-2; GM-Tg-cynog-SE1278-Ab-1/ GM-Tg-cynog-SE1278-Ab-2;
GM-Tg-felg-SE1278-Ab-1/ GM-Tg-felg-SE1278-Ab-2; GM-Tg-cang-SE1278-Ab-1/ GM-Tg-cang-SE1278-Ab-2;
GM-Tg-bovg-SE1278-Ab-1/ GM-Tg-bovg-SE1278-Ab-2; GM-Tg-equg-SE1278-Ab-1/ GM-Tg-equg-SE1278-Ab-2
Products NameAnti-SERPINA4 monoclonal antibody
Formatmab
Target NameSERPINA4
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SERPINA4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1278-Ag-1Recombinant multi-species KAIN/ SERPINA4/ KAL protein
    ORF Viral VectorvGMLP004148human SERPINA4 Lentivirus particle
    ORF Viral VectorpGMLP004148human SERPINA4 Lentivirus plasmid


    Target information

    Target IDGM-SE1278
    Target NameSERPINA4
    Gene ID5267,246328,701846,490840,101081642,786932
    Gene Symbol and SynonymsKAL,kallistatin,KLST,KST,PI-4,PI4,SERPINA4
    Uniprot AccessionP29622
    Uniprot Entry NameKAIN_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000100665
    Target ClassificationN/A

    The target: SERPINA4, gene name: SERPINA4, also named as KAL, KLST, KST, PI-4, PI4, kallistatin. Predicted to enable serine-type endopeptidase inhibitor activity. Predicted to be involved in negative regulation of endopeptidase activity. Located in extracellular exosome. Biomarker of diabetic retinopathy. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.